Patient access, triage, and agents
SkinVision
AI-powered skin cancer detection app that provides a risk assessment for uploaded skin spots and is CE-certified under EU MDR Class IIa.
Last updated: June 5, 2026
Back to directoryWoebot Health medical AI product profile
Digital mental health company building chat-based AI wellness tools and investigational behavioral-health digital therapeutics with published AI, safety, privacy, and regulatory disclosures.
Patient access, triage, and agents
Best fit
Organizations evaluating supervised mental-health support programs that need a vendor with explicit AI principles, clinical research posture, privacy controls, and stated crisis-service limits.
- Primary use case
- AI-supported mental health conversation, structured self-guided support, research-grade digital therapeutic development, and partner-sponsored behavioral health access
- Audience
- Health systems, behavioral health partners, payers, researchers, and digital mental health teams evaluating chat-based AI wellness or investigational digital therapeutics
- Risk level
- High
- Pricing signal
- Partner and program terms are not publicly listed; request current product availability, population, clinical scope, and contracting details.
- Official sources
- 6 official sources
Compare within workflow: Patient access, triage, and agents · comparison shortlist · source index
Regulatory, privacy, evidence, and workflow lens
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Woebot Health as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat as high-risk behavioral-health software. Breakthrough Device Designation for WB001 is not the same as FDA clearance, and Woebot's own AI principles page identifies W-DISC-MVP as investigational and not FDA evaluated, cleared, or approved. |
|---|---|
| Privacy | Review privacy policy, PHI handling, HIPAA posture, partner data sharing, third-party model or service-provider use, data retention, user rights, and whether organization-specific BAA or DPA terms cover the planned workflow. |
| Evidence | Separate broad wellness claims from product-specific evidence. Require current trial status, peer-reviewed publications, safety data, population fit, crisis-performance evidence, and outcome measures for the exact product version. |
| Workflow | Govern as supplemental mental-health support or clinician-supervised digital-therapeutic access, with explicit crisis routing, excluded-use rules, partner responsibilities, human escalation, and incident review. |
Where Woebot Health fits
Woebot Health describes chat-based AI wellness tools and an AI governance approach with clinical oversight, testing, IRB-reviewed studies, HIPAA-oriented data handling, and limits on crisis intervention; company announcements describe FDA Breakthrough Device Designation and a pivotal trial for the investigational WB001 postpartum-depression digital therapeutic.
Not for: Emergency counseling, suicide prevention, autonomous diagnosis, replacement therapy, or assuming FDA Breakthrough Device Designation means FDA clearance or broad marketing authorization.
What to verify before using Woebot Health
- Which Woebot product or program is actually available: general Woebot Health platform, partner-sponsored wellness access, WB001, W-DISC-MVP, research study, or another product version.
- Whether any FDA Breakthrough Device Designation, investigational-device statement, or clinical-trial result applies to the intended condition, user group, region, and deployment date.
- How user conversations, PHI, sensitive mental-health data, LLM or machine-learning processing, third-party service providers, partner reporting, retention, and deletion rights are handled.
- Crisis limitations, concerning-language handling, escalation design, clinician or partner responsibilities, safety committee review, IRB oversight, and local monitoring for self-harm or deterioration.
Source links
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
- woebothealth.com
- woebothealth.com / technology-overview
- woebothealth.com / ai-core-principles
- woebothealth.com / privacy-webview
- woebothealth.com / woebot-health-receives-fda-breakthrough-device-designation
- woebothealth.com / woebot-health-enrolls-first-patient-in-pivotal-clinical-trial-of-wb001-for-postpartum-depression
Related medical AI products
Patient access, triage, and agents
Hippocratic AI
Healthcare-focused generative AI agent platform with role-specific voice agents, patient access workflows, and inpatient nurse co-pilot positioning.
Patient access, triage, and agents
Tucuvi
Clinical voice AI and patient-management platform using LOLA for outbound or inbound patient conversations, alert routing, and clinician dashboard workflows.
Patient access, triage, and agents
Infermedica
AI symptom analysis and triage platform that can be embedded into healthcare journeys.